UiPath, Inc. (PATH) is a New York-based enterprise automation software company and a global leader in robotic process automation (RPA) and agentic AI platforms, serving thousands of organizations worldwide. Shares dropped approximately 10% in premarket trading on March 12, 2026, from the prior session's closing price of $12.38, placing the stock near the $11.15 level. The prior regular-session close on March 11 was $12.38, which itself represented a nearly 7% intraday gain on earnings optimism — a gain that has now been entirely erased in the after-market reaction. The selloff was triggered by a mix of a GAAP EPS miss and, critically, fiscal 2027 guidance that fell short of investors' growth acceleration hopes.
UiPath reported Q4 fiscal 2026 revenue of $481.1 million, a 14% year-over-year increase that topped Wall Street's consensus estimate of approximately $464.9 million by more than $16 million. On a Non-GAAP basis, EPS came in at $0.30, beating estimates of $0.25 by $0.05. However, GAAP EPS of $0.19 fell materially short of the $0.26 consensus, a miss of roughly 27%, which drew scrutiny from investors focused on bottom-line accountability. Full-year fiscal 2026 revenue totaled $1.611 billion — up 13% year-over-year — and the company achieved GAAP operating income of $57 million for the full year, its first-ever full-year GAAP profitability milestone.
The dominant driver behind the post-earnings selloff was the FY2027 revenue outlook. Management guided full-year fiscal 2027 revenue to $1.754–$1.759 billion, implying approximately 8–9% growth compared to FY2026's $1.611 billion — a meaningful deceleration from the 13% growth rate just delivered. For Q1 FY2027, the company guided revenue of $395–$400 million and non-GAAP operating income of approximately $80 million — broadly in line with, rather than ahead of, market consensus. In a market that had priced in continued high-growth execution from an AI-leveraged automation platform, guidance that signals a transition to slower, more mature growth was read as a material disappointment. The lack of a clear "beat-and-raise" narrative on the top line effectively reset investor expectations downward.
Annual Recurring Revenue (ARR) reached $1.853 billion at the end of Q4, up 11% year-over-year, consistent with the prior quarter's pace rather than showing any acceleration. The dollar-based net retention rate of 107% — while positive — suggests limited expansion velocity from within the existing customer base, a metric that high-multiple software investors closely monitor. The number of customers with ARR above $1 million grew from 317 to 357 year-over-year, demonstrating continued enterprise momentum, but the overall growth cadence fell short of the inflection point many investors were looking for.
Adding to investor unease, CEO Daniel Dines and CFO Ashim Gupta have both recently sold shares, and the earnings release noted that the company repurchased 14 million shares at an average price of $12.11 between February 1 and March 10 — near current trading levels. While the $500 million buyback authorization signals management's confidence in intrinsic value, CEO share sales alongside a guidance reset created a mixed sentiment environment, particularly for momentum-oriented investors.
The premarket decline follows a "sell the news" pattern that has become common in software earnings. PATH had rallied significantly in the days leading up to its March 11 results, gaining roughly 24.55% over the prior two weeks. The stock's rapid ascent ahead of earnings left it vulnerable to a sharp pullback on any guidance miss or lack of a meaningful upside surprise. Volume in recent sessions has been significantly elevated relative to average daily volume, consistent with options-driven activity and speculative positioning ahead of the event. The broader enterprise software sector has also faced headwinds from macro uncertainty and interest rate sensitivity, providing little cushion for valuation-multiple compression in the face of decelerating growth guidance.
For investors navigating volatile earnings-driven moves like PATH's, Tickeron's Trending AI Robots page offers a curated view of the highest-performing AI trading bots currently active on the platform. Tickeron operates hundreds of AI-powered bots covering thousands of tickers, but only those delivering the strongest results under prevailing market conditions are featured in this Trending section. Each bot is distinct in strategy, timeframe, performance metrics, and the symbols it trades — ranging from short-term momentum plays to swing and position strategies. Whether you are looking to act on a sharp premarket move or position for a post-earnings recovery, exploring the Trending AI Robots section may surface tools aligned with your trading style and risk tolerance.
The next major milestone for PATH investors will be the Q1 FY2027 earnings report, where the market will assess whether the guided revenue range of $395–$400 million is achieved or exceeded. Analysts will focus on whether AI-driven ARR — which contributed $200 million in the most recent period — can continue expanding and whether the dollar-based net retention rate shows any recovery above its current 107% level. With a consensus analyst rating of "Hold" and a range of price targets from the mid-teens to $19, the path forward hinges largely on UiPath's ability to demonstrate that its Agentic Automation strategy can reignite top-line growth beyond the currently guided 8% trajectory. Macro headwinds, competitive dynamics in the AI automation space, and broader enterprise IT spending trends will also remain key variables for PATH shareholders to monitor in the months ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
PATH moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend. In 38 of 46 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 83%.
The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PATH as a result. In 62 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The 10-day moving average for PATH crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PATH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for PATH entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PATH's RSI Oscillator exited the oversold zone, 22 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 68 cases where PATH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for PATH just turned positive on October 05, 2026. Looking at past instances where PATH's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.
Following a +8.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where PATH advanced for three days, in 238 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
PATH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.261) is normal, around the industry mean (18.522). P/E Ratio (18.194) is within average values for comparable stocks, (158.311). Projected Growth (PEG Ratio) (0.447) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (4.248) is also within normal values, averaging (104.490).
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. PATH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PATH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications